PSIXPSIXNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+210.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+210.5%/yr
vs -17.1%/yr prior
Acceleration
+227.6pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
29.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 90.69% |
| Q3 2025 | 3.79% |
| Q2 2025 | 8.74% |
| Q1 2025 | -19.15% |
| Q4 2024 | 12.86% |
| Q3 2024 | -6.21% |
| Q2 2024 | -4.58% |
| Q1 2024 | -4.27% |
| Q4 2023 | 14.01% |
| Q3 2023 | 2.15% |
| Q2 2023 | 1.26% |
| Q1 2023 | -7.27% |
| Q4 2022 | 3.03% |
| Q3 2022 | 5.82% |
| Q2 2022 | -0.13% |
| Q1 2022 | -2.21% |
| Q4 2021 | -14.24% |
| Q3 2021 | -11.03% |
| Q2 2021 | -1.82% |
| Q1 2021 | -0.48% |
| Q4 2020 | -4.59% |
| Q3 2020 | 12.75% |
| Q2 2020 | -13.89% |
| Q1 2020 | 8.26% |
| Q4 2019 | -2.03% |
| Q3 2019 | 5.57% |
| Q2 2019 | -4.27% |
| Q1 2019 | -20.37% |
| Q4 2018 | 2.62% |
| Q3 2018 | 10.72% |
| Q2 2018 | 15.63% |
| Q1 2018 | -6.78% |
| Q4 2017 | 13.32% |
| Q3 2017 | 50.00% |
| Q2 2017 | -5.00% |
| Q1 2017 | -14.89% |
| Q4 2016 | 4.44% |
| Q3 2016 | -6.25% |
| Q2 2016 | -8.57% |
| Q1 2016 | 11.51% |